– Early data points to safety and early efficacy of Bria-IMT™ in Advanced Stage IV ...
AUSTIN, Texas—3/9/18– SmallCapVoice.com, Inc. and BriaCell Therapeutics Corp. (“BriaCell”) (BCT.V) (BCTXF), an immuno-oncology focused biotechnology ...
– Early Evidence of Safety and Impressive Anti-Tumor Activity of Bria-IMT™- BERKELEY, Calif. and VANCOUVER, ...
BERKELEY, Calif. and VANCOUVER, British Columbia, April 3, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, March 27, 2018 — BriaCell Therapeutics Corp. (“BriaCell” or ...
BERKELEY, Calif. and VANCOUVER, British Columbia, March 14, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, March 07, 2018 –BriaCell Therapeutics Corp. (“BriaCell” or the ...
BERKELEY, Calif. and VANCOUVER, British Columbia, March 1, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, February 7, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, February 6, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
Accessibility Tools